... of urethral resistance in doxazosin-treated patients. Conclusion: These results indicate that doxazosin is an important treatment option for patients with troublesome lower urinary tract symptoms and BPO. 19 2 2019 European Urology Clinical Paper Eur Urol 1997;32:39-46 1617495 Paul Abrams Bristol...

...M. O’Leary Measurement of lower urinary tract symptoms in patients with benign prostatic hyperplasia (BPH) is extremely important as it is these symptoms which account for much of the morbidity associated with this disease. The symptoms of BPH interfere with factors affecting the patient’s health...

...C.R. Chapple; L. Baert; P. Thind; K. Höfner; G.S.S. Khoe; A. Spångberg Objectives: To compare the safety and tolerability of tamsulosin 0.4 mg once daily in younger (<65 years) and older (≥65 years) patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO...

..., instructions or products referred to in the content or advertisements. Epidemiology Benign prostatic hyperplasia Lower urinary tract symptoms Life-style Table 2 IPSS-symptom score by grouped concomitant disease The QUIBUS study, at this stage of evaluation which refers only...

...Domenico Prezioso; Roberto Maria Scarpa; Filiberto Zattoni; Stefano Viaggi; Roberta Termini; Silvano Berioli; Carlo Alessandro Rizzi Objective: Few epidemiological studies are available on Italian patients with lower urinary tract symptoms and their QoL. QUIBUS (QUality of life Investigated in BPH...

... hyperplasia Lower urinary tract symptoms Sexual function Sexuality is an important aspect of quality of life (QoL) in patients with benign prostatic hyperplasia (BPH) [ 1, 2, 3 ]. BPH may indeed be responsible for a loss or decrease in sexual function and its treatment, both surgical...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Epidemiology Benign prostatic hyperplasia Lower urinary tract symptoms IPSS ICS-BPH Quality of life In recent years, it has become increasingly evident that BPH...

... symptoms Benign prostatic hyperplasia Uroflowmetry IPSS ICS-BPH Quality of life Uroflowmetry has a controversial role in the evaluation of benign prostatic hyperplasia (BPH) and is regarded at present as an optional test for men with lower urinary tract symptoms (LUTS). This is due mainly...

... to in the content or advertisements. Epidemiology Benign prostatic hyperplasia Lower urinary tract symptoms Management of patients To enhance appropriate and effective care of BPH, the Agency of Health Care Policy and Research (AHCPR) and the World Health Organisation (WHO) have published practice...

...Richard R. Berges; L. Pientka; K. Höfner; T. Senge; U. Jonas Objectives: To investigate the prevalence of lower urinary tract symptoms (LUTS) and LUTS– related health care issues in the male population between the ages of 50 and 80 in Germany. Methods: 8,973 randomly chosen men in the age group...

... the economic perspective, the primary objective of the Triumph project is the assessment of the cost-effectiveness of treatment options for lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO), formerly referred to as symptomtic benign prostatic hyperplasia (BPH), in medical...

... urinary tract symptoms Benign prostatic obstruction Medical therapy Surgery Primary care Secondary care Healthcare delivery Lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) is a common condition in the male population. Over the age of 40, the prevalence...

...John W. Logie; Gary M. Clifford; Richard D.T. Farmer; Bianca P.W. Meesen The Triumph project aims to document the current management of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in general practice and to assess the effectiveness of the initial treatment...

...Christopher R. Chapple Lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) are likely to become an increasing burden for health care budgets in the future due to the high prevalence of this condition in the elderly and the ageing of the population. Data on the cost...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Benign prostate hyperplasia Prostatic obstruction Lower urinary tract symptoms Adrenoceptor alpha-blockade...

... and prostate volume, and a negative correlation between IPSS and peak flow rate (r = –0.278). There was a modest correlation between body mass index (BMI) and prostate size, but no significant correlation between BMI and IPSS. Conclusion: In this population–based study, moderate lower urinary tract symptoms...

...G.M. Clifford; J. Logie; R.D.T. Farmer Objective: Lower urinary tract symptoms (LUTS) are usually, but not exclusively associated with benign prostatic hyperplasia (BPH). Using a population identified from the UK General Practice Research Database (GPRD), we describe the changes in the management...

... external validity. Hence, RCTs and RLP studies should not be considered as mutually exclusive but rather as complementing each other. Specific advantages and disadvantages of RCTs and RLP studies will be discussed using published evidence for the treatment of lower urinary tract symptoms suggestive...

...Christian De Mey Randomised controlled trials (RCTs) provide the best available external evidence for the use of α 1 -blockers in treating lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO). Placebo-controlled and actively-controlled RCTs evidenced the efficacy...

...Stephan Madersbacher; Georg Schatzl; Bob Djavan; Thomas Stulnig; Michael Marberger Objective: The aim of this study was to determine the long–term outcome after transrectal high–intensity focused ultrasound (HIFU) therapy for patients with lower urinary tract symptoms (LUTS) due to benign prostatic...